There are no data with Coagulation Factor IX (Recombinant), Albumin Fusion Protein use in pregnant women to inform on drug-associated risk. Animal reproduction studies have not been conducted using Coagulation Factor IX (Recombinant), Albumin Fusion Protein. It is not known whether Coagulation Factor IX (Recombinant), Albumin Fusion Protein can cause fetal harm or affect reproduction capacity when administered to a pregnant woman. Coagulation Factor IX (Recombinant), Albumin Fusion Protein should be given to a pregnant woman only if clearly needed.
